Retatrutide In the first phase 3 trial (TRIUMPH-4), participants lost an average of 28.7% of their body weight at 68 weeks on the highest dose (12mg), with the 9mg dose showing 26.4% weight loss
Eat 5-6 small, low-fat meals daily
For this analysis, we studied 14,210 subscribers who tracked their weight at weeks 4, 8, 16, and 40
Western medicine is ostensibly based on scientific research and clinical trials to determine the effectiveness of treatments
The stomach: delayed gastric emptying
16.8% average weight loss at 12 mg 2.0% HbA1c reduction at 12 mg Discontinuation due to side effects: 5.1% at 12 mg notably lower than the obesity-only TRIUMPH trials Dysesthesia also lower in this population The lower side-effect rate in the diabetes population is not fully explained yet